Mission With Alzheimer’s Disease, Memory Loss, and the quest for mental improvement touching the lives of millions of Americans and people around the world, we are pleased to introduce you to our company – where science, information, and people come together to provide a helping hand 800 El Camino Real Suite 180 Mountain View, CA (650)

Cognitive Labs Market “77 Million People in the U.S. are ‘Aging Baby Boomers’ who need to monitor their memory” “Alzheimer’s Disease is a National Crisis” with 12 million expected cases over the next decade and a half.” U.S. Senate

Imperative: Slow down Alzheimer’s and MCI Research has shown correlation between intensive cognitive exercise and prevention or delay of Alzheimer’s for up to 20 years Why? Exercises strengthen links between centers of memory in the brain by building neurons – activity slows formation of harmful proteins (Plaque) that impair mental functioning Our body of research demonstrates that our tests are sensitive enough to detect cognitive impairment Cognitive Labs allows screening over time, so individuals can monitor their progress, furthermore the architecture and implementation enables Always-on access for consumer, scientific, and institutional applications.

Cognitive Labs What We Do Using patent-protected technology, we deliver unique software-based tracking and diagnostic services to people over the internet, with consumer, scientific, and medical applications.

Cognitive Labs Consumer We operate cognitivecare.com, the leading Alzheimer’s site featuring MemCheck, and Memory for Life memory management services while building the world’s largest cognitive database Key facts this year: Visitors: over 200,000 New members per month: over 5,000

Cognitive Labs Consumer Trends – Customer acquisition through Search, Affiliate, Asymmetric Advertising, Retail POS (prepaid ‘MemCheck’ card, Crossover Media Total Available Market: 77,000,000 people in the U.S. alone (Alz.org, Intel) 2.0% conversion rate = 1,540,000 subscribers

Cognitive Labs Medical Google is the #1 source of health information for professionals according to the Academy of Internal Medicine – we leverage search to educate and deliver an intuitive service: MemCheck Professional Market size: 690,000 M.D.s are licensed in the U.S (AMA) 150,000 Psychologists are licensed ( APA)

Cognitive Labs Enterprise We sell software to research institutions, pharmaceutical and biotechnology firms. Applications include cognitive monitoring and screening for memory loss and objective measurement of the impact of various stimuli on cognition. Market size: 4,000 institutions.

Cognitive Labs IP Licensing The company has been awarded 2 patents on interactive computerized cognitive monitoring and numerous trademarks, a third is in the office action phase. Market size: Firms now entering this market may decide that a license of one or several of our platform patents is valuable.

Cognitive Labs Analytics The relational database captures information from every user on memory, cognition, reaction time, and other self- reported factors. We have developed memory norms and are exploring new uses for the data. We believe we have built the world’s largest database of reaction times for individuals related to memory and cognitive performance, illustrating changes over time, impact of nutrition, and other factors.

Cognitive Care Stanford (Research Partner) Syndication and search Cognitive Labs

Content driven placement

Cognitive Labs

“I have used and reviewed the Cognitive Labs services and find them quite helpful and timely for the growing market to detect early stages of cognitive dysfunction, e.g., mild cognitive impairment (MCI)...I can see in the future widespread use of this memory screening service provided by primary care physicians.” Yogesh Shah, M.D., Associate Program Director, Mercy/Mayo Family Practice Residency Program, a Mayo Clinic facility, Board Member, Iowa Alzheimer’s Association Testimonials

“I have reviewed the software developed by Cognitive Labs and believe it is sufficiently developed to now serve an emerging new market for the early detection and diagnosis of cognitive impairment…[and] may be an ideal instrument for both the selection of incipient brain disorders or disease, and the monitoring of subtle state changes to quantify disease progression, or improvement from therapy (medication, etc.)” Arthur Jensen, Ph.D., Professor Emeritus, Educational Psychology University of California, Berkeley Member Top 100 Psychologists of the 20 th Century (APA) Testimonials

“I have been using the Cognitive Labs testing and training services in my preventative medicine/anti- aging practice…I have found the tests helpful in screening for early stage cognitive impairment, and in establishing a cognitive baseline so that I am better able to quantify outcomes…” Ron Rothenberg, M.D., Professor, UCSD Medical School, Founder, California Healthspan Institute Testimonials